
Sign up to save your podcasts
Or


A native of Sweden, Helena Cowley moved to the U.S. in 2009 as a teenager. She is the CEO of Captozyme, a company that developed an enzyme to degrade oxalates, a key component of kidney stones and possibly the source of other problems for the body.
By The Cade MuseumA native of Sweden, Helena Cowley moved to the U.S. in 2009 as a teenager. She is the CEO of Captozyme, a company that developed an enzyme to degrade oxalates, a key component of kidney stones and possibly the source of other problems for the body.